Wako, Japan

Shigeki Nunomura


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 43(Granted Patents)


Location History:

  • Wako, JP (1992 - 1995)
  • Iruma, JP (1998)

Company Filing History:


Years Active: 1992-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Shigeki Nunomura: Innovator in Immuno-Stimulating Compounds

Introduction

Shigeki Nunomura is a notable inventor based in Wako, Japan. He has made significant contributions to the field of immunology and cancer treatment through his innovative patents. With a total of 3 patents, Nunomura's work has garnered attention in both academic and industrial circles.

Latest Patents

Among his latest patents are the Lewis-associated compound and the process for producing the same. Additionally, he has developed oligosialyl-1,2-dialkyl-sn-glycerols and synthetic intermediates for an oligosialyl-1,2-dialkyl-sn-glycerol. This compound is represented by a specific formula, where each R¹ independently represents a group selected from hydrogen atoms and alkali metal atoms. Each R² independently represents an alkyl group having 14 to 18 carbon atoms, with Ac representing an acetyl group. The integer n ranges from 0 to 20. These compounds are useful as immuno-stimulating agents, antitumor agents, and diagnostic and therapeutic agents for cancers.

Career Highlights

Shigeki Nunomura has worked with prominent companies such as Mect Corporation and Rikagaku Kenkyusho. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in his field.

Collaborations

Some of his notable coworkers include Tomoya Ogawa and Mamoru Sugimoto. Their collaborative efforts have further advanced the research and development of innovative compounds.

Conclusion

Shigeki Nunomura's contributions to the field of immunology and cancer treatment through his patents highlight his role as a significant inventor. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…